Phosphalohydrins and methods for medicinal administration
AssigneeInstitut National de la Sante et de la Recherche Medicale
InventorsChristian Belmant, Jean-Jacques Fournie, Marc Bonneville, Marie-Alix Peyrat
Life of this patent
Estimating the term…
Abstract
The invention provides compounds comprising at least one phosphohalohydrin group of the formula: where X is a halogen selected from among I, Br, Cl, R1 is selected from among —CH3 and —CH2—CH3, Cat+ is an organic or inorganic cation, and n is an integer between 2 and 20, processes for the production thereof and uses thereof, in particular therapeutic uses and for activating primate Tγ9δ2 lymphocytes.
Claims14
A phosphohalohydrin compound of the formula:
- where X is a halogen selected from I, Br, and Cl,
- R1 is selected from —CH3 and —CH2—CH3
- Cat+ is a cation,
- and n is an integer between 2 and 20.
A phosphohalohydrin compound of the formula:
- where X is a halogen selected from I, Br, and Cl,
- R1 is selected from —CH3 and —CH2—CH3
- Cat+ is a cation,
- and n is an integer between 2 and 20.
A phosphohalohydrin compound of the formula:
- where X is a halo group selected from I, Br and Cl,
- R1 is selected from —CH3 and —CH2—CH3,
- Cat+ represents a cation, which may be identical or different in the same compound,
- n is an integer between 2 and 20,
- R3- is selected from:
- a halohydrin group of the formula:
- an epoxide group of the formula:
- and an alkene group of the formula:
- m being an integer between 1 and 20.
Dependencies are inferred from the claim text.